Connection

Harry Clarke to Cholestenone 5 alpha-Reductase

Back to Details
This is a "connection" page, showing publications Harry Clarke has written about Cholestenone 5 alpha-Reductase.
Harry Clarke
Connection Strength
0.329
Cholestenone 5 alpha-Reductase
  1. Combination 5-alpha-reductase inhibitors and alpha-blockers for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2008 Jul; 9(4):291-4.
    View in: PubMed
    Score: 0.329
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.